Evaluation of genetically engineered herpes simplex viruses as oncolytic agents for human malignant brain tumors.
Evaluation of genetically engineered herpes simplex viruses as oncolytic agents for human malignant brain tumors. Cancer Res. 1997 Apr 15; 57(8):1502-9.